TokenPost topic
1 TokenPost story is tagged Phase 1 trial. The newest appear first.
The result came from 25 evaluable patients given 450 milligrams every three weeks; BeOne plans larger trials by the end of 2026.
Oct 24, 2026, 1:10 PM EDT ยท Business